A single case report has shown that the FGFR inhibitor BGJ398 did demonstrate partial response in a patient with squamous cell lung carcinoma whose tumor was amplified for FGFR1 [6]. This evidence concerns the gene FGFR1 and squamous cell lung carcinoma.